Guidance on the licensing of biosimilar products

This guideline, which outlines the requirements for biosimilar products, contains further clarifications and some revisions to CHMP guidelines, which take into account the scientific and regulatory experience gained since the first biosimilar was licensed in 2006.

Source:

Medicines and Healthcare products Regulatory Agency